Increased Serum Nesfatin-1 Levels in Patients with Impaired Glucose Tolerance

---

Atıf İçin Kopyala

Akin S., Gulcelik N. E., Aksoy D. Y., Karakaya J., Usman A.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, cilt.21, sa.3, ss.65-67, 2017 (ESCI)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 21 Sayı: 3
• Basım Tarihi: 2017
• Doi Numarası: 10.25179/tjem.2017-56543
• Dergi Adı: TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.65-67
• Hacettepe Üniversitesi Adresli: Evet

Özet

Purpose: Nesfatin-1 is a recently discovered energy-regulating peptide, widely expressed in both central and peripheral tissues. It is involved in various functions, such as the stimulation of hypothalamic-pituitary-adrenal axis and sympathetic nervous system, influencing visceral functions, water intake, and regulation of temperature and emotions. It exerts a direct glucose-dependent insulinotropic action on the beta cells of pancreatic islets. The current study evaluated nesfatin-1 levels and insulin response to glucose load in patients with impaired glucose tolerance (IGT) and in healthy subjects.